Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients

NMR in Biomedicine

Volumn 23, Issue 3, 2010, Pages 257-261

  Nagarajan, Rajakumar ^a   Gomez, Ana M ^a   Raman, Steve S ^a   Margolis, Daniel J ^a   McClure, Tim ^a   Thomas, M Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2D JPRESS; Magnetic resonance spectroscopy; Pathological Gleason score; Prostate cancer

Indexed keywords

CLINICAL SETTINGS; GLEASON SCORES; J-RESOLVED SPECTROSCOPY; PATHOLOGICAL GLEASON SCORE; PILOT STUDIES; PROSTATE CANCERS;

BIOMOLECULES; CHROMIUM; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; METABOLITES; PARTICLE DETECTORS; PATHOLOGY;

DISEASES;

CHOLINE; CITRIC ACID; CREATINE; PROTON; SPERMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EX VIVO STUDY; GLEASON SCORE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC FIELD; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SPECTROSCOPY; TWO DIMENSIONAL J RESOLVED SPECTROSCOPY;

AGED; CHOLINE; CITRIC ACID; CREATINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RECTUM; SPERMINE;

EID: 77949668382     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1446     Document Type: Article

References (44)

1. Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlock CA, Holmberg L, Bailey DE Jr, Wallace ME, Kantoff PW, Carroll PR. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008; 112(8): 1650-1659.
2. McNeal JE. Normal histology of the prostate. Am. J. Surg. Pathol. 1988; 12: 619-633.
3. Jager GJ, Ruijter ET, van de Kaa CA, de la Rosette JJ, Oosterhof GO, Thornbury JR, Ruijs SH, Barentsz JO. Dynamic Turbo FLASH subtraction technique for contrast-enhanced MR imaging of the prostate correlation with histopathologic results. Radiology. 1997; 203: 645-652.
4. Nakashima J, Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology. 2004; 64: 101-105.
5. Kattan MW, Eastham JA, Stapleton AMF, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J. Natl. Cancer Inst. 1998; 90: 766-771.
6. Kattan MW, Zelefsky MJ, Kupelian PA, Scardino PT, Fuks Z, Leibel SA. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J. Clin. Oncol. 2000; 18: 3352-3359.
7. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA. 1995; 274: 626-631.
8. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J. Urol. 2003; 169: 517-523.
9. Purohit RS, Shinohara K, Meng MV, Carroll PR. Imaging clinically localized prostate cancer. Urol. Clin. North Am. 2003; 30: 279-293.
10. Donahue T, Moul T. Diagnostic accuracy of prostate needle biopsy. Curr. Urol. Rep. 2002; 3: 215-221.
11. Djavan B, Keith Kadesky, Boris Klopukh, Michael Marberger, Claus G. Roehrborn Gleason Scores from Prostate Biopsies Obtained with 18-Gauge Biopsy Needles Poorly Predict Gleason Scores of Radical Prostatectomy Specimens. Eur. Urol. 1998; 33: 261-270.
12. Rajinikanth A, Manoharan M, Soloway CT, Civantos FJ, Soloway MS. Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years. Urology. 2008; 72(1): 177-182.
13. Sanchez-Chapado M, Angulo JC, Ibarburen C, Aguado F, Ruiz A, Viaño J, García-Segura JM, Gonzalez-Esteban J, Rodriquez-Vallejo JM. Eur. Urol. 1997; 32: 140-149.
14. Ito H, Kamoi K, Yokoyama K, Yamada K, Nishimura T. Visualization of prostate cancer using dynamic contrast enhanced MRI: comparison with transrectal power Doppler ultrasound. Br. J. Radiol. 2003; 76: 617-624.
15. Thomas MA, Narayan P, Kurhanewicz J, Jajodia P, Weiner MW. 1H MR spectroscopy of normal and malignant human prostates in vivo. J. Magn. Reson. 1990; 87: 610-619.
16. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology. 1995; 3: 459-466.
17. Heerschap A, Jager GJ, van der Graaf M, Barentsz JO, Ruijs SH. Proton MR Spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence. Magn. Reson. Med. 1997; 37: 204-213.
18. Wu CL, Taylor JL, He W, Zepeda AG, Halpern EF, Bielecki A, Gonzalez RG, Cheng LL. Proton high-resolution magic angle spinning NMR analysis of fresh and previously frozen tissue of human prostate. Magn. Reson. Med. 2003; 50: 1307-1311.
19. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopy with step section histology. J. Urol. 2000; 164: 400-404.
20. Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll PR, Kurhanewicz J. Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magn. Reson. Med. 2001; 46: 49-57.
21. Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, Muruganandham M, Ebora L, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Correlation of Proton MR Spectroscopic Imaging with Gleason Score Based on Step-Section Pathologic Analysis after Radical Prostatectomy. Radiology 2005; 234(3): 804-814.
22. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer. 2004; 4: 781-792.
23. Medina MA, Correa-Fiz F, Rodriguez-Caso C, Sanchez-Jimenez F. A comprehensive view of polyamine and histamine metabolism to the light of new technologies. J. Cell. Mol. Med. 2005; 9: 854-864.
24. Schipper RG, Romijn JC, Cuijpers VM, Verhofstad AA. Polyamines and prostatic cancer. Biochem. Soc. Trans. 2003; 31: 375-380.
25. Takyi EE, Fuller DJ, Donaldson LJ, Thomas GH. Deoxyribonucleic acid and polyamine synthesis in rat ventral prostrate: effects of age of the intact rat and androgen stimulation of the castrated rat with testosterone, 5 alpha-dihydrotestosterone and 5 alpha-androstane-3 beta, 17 beta-diol. Biochem. J. 1977; 162: 87-97.
26. Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem. J. 2003; 376: 1-14.
27. Cohen RJ, Fujiwara K, Holland JW, McNeal JE. Polyamines in prostatic epithelial cells and adenocarcinoma: the effects of androgen blockade. Prostate 2001; 49: 278-284.
28. Kurhanewicz J, Dahiya R, Macdonald JM, Chang LH, James TL, Narayan P. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study. Magn. Reson. Med. 1993; 29: 149-157.
29. Cheng LL, Wu C, Smith MR, Gonzalez RG. Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T. FEBS Lett. 2001; 494: 112-116.
30. Van der Graaf M, Schipper RG, Oosterhof GO, Schalken JA, Verhofstad AA, Heerschap A. Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. MAGMA. 2000; 10: 153-159.
31. Yue K, Marumoto A, Binesh N, Thomas MA. 2D JPRESS of human prostates using an endorectal receiver coil. Magn. Reson. Med. 2002; 47: 1059-1064.
32. Ryner LN, Sorenson JA, Thomas MA. Localized 2D 1H MR spectroscopy: strong coupling effects in vitro and in vivo. Magn. Res. Imag. 1995; 13: 853-869.
33. Thomas MA, Ryner LN, Mehta MP, Turski PA, Sorenson JA. Localized 2D J-resolved 1H MR spectroscopy of human brain tumors in vivo. J. Magn. Reson. Imag. 1996; 6: 453-459.
34. Thomas MA, Marumoto A, Binesh N, Yue K, Barbaric Z. Levels of Citrate, spermine, choline in human prostate using transrectal MR spectroscopy. 86th Scientific Assembly and RSNA Meeting, Chicago, USA. 2000; 365.
35. Swanson MG, Vigneron DB, Tran TK, Sailasuta N, Hurd RE, Kurhanewicz J. Single-voxel oversampled J-resolved spectroscopy of in vivo human prostate tissue. Magn. Reson. Med. 2001; 45: 973-980.
36. Males RG, Vigneron DB, Star-Lack J, Falbo SC, Nelson SJ, Hricak H, Kurhanewicz J. Clinical application of BASING and spectral-spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn. Reson. Med. 2000; 43: 17-22.
37. Brooker HR, Mareci TH, Mao JT. Selective Fourier transform localization. Magn. Reson. Med. 1987; 5: 417-433.
38. Ogg RJ, Kingsley PB, Taylor JS. WET, a T1-and B1-insensitive water suppression method for in vivo localized 1H MR Spectroscopy. J. Magn. Reson. 1994; 104B: 1-10.
39. Kumar A. Two-dimensional spin-echo NMR spectroscopy: a general methodfor calculation of spectra. J.Magn. Reson. 1978; 30: 227-249.
40. Wilman AH, Allen PS. The response of the strongly coupled AB system of citrate to typical 1H MRS localization sequences. J. Magn. Reson. 1995; 107: 25-33.
41. Fütterer JJ, Scheenen TW, Heijmink SW, Huisman HJ, Hulsbergen-Van de Kaa CA, Witjes JA, Heerschap A, Barentsz JO. Standardized threshold approach using three-dimensional Proton Magnetic Resonance Spectroscopic Imaging in prostate cancer localization of the entire prostate. Inv. Radiology Feb. 2007; 42(2): 116-122.
42. Serkova NJ, Gamito EJ, Jones RH, O'Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate 2008; 68(6): 620-628.
43. Kim DH, Margolis D, Xing L, Daniel B, Spielman D. In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at3 T. Magn. Reson. Med. 2005; 53(5): 1177-1182.
44. Lange T, Schulte RF, Boesiger P. Quantitative J-resolved prostate spectroscopy using two-dimensional prior-knowledge fitting. Magn. Reson. Med. 2008; 59(5): 966-972.